COGT Stock Analysis: Buy, Sell, or Hold?
COGT - Cogent Biosciences, Inc. Common Stock
$35.39
-0.71 (-1.97%)
▼
5d:
-0.06%
30d:
-8.91%
90d:
-8.98%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Smart Money Accumulation
COGT is down 4.7% this week, but smart money is accumulating calls. Top strike: $41 2026-04-17 with 229 OI. Call ratio: 94% View Scanner →
Strength: 6.8/10
Get Alerted When COGT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: COGT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: COGT shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: COGT is currently trading at $35.39, which is considered slightly low relative to its 30-day fair value range of $34.96 to $38.30.
Technical Outlook: Technically, COGT is showing sideways momentum. Immediate support is located at $32.70, while resistance sits at $37.04.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.17 (+53.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, COGT is showing sideways momentum. Immediate support is located at $32.70, while resistance sits at $37.04.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $54.17 (+53.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$34.96 -
$38.30
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 53.1% below Wall St target ($54.17)
Fair Price Analysis
30-Day Fair Range
$34.96 -
$38.30
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$32.70
Resistance Level
$37.04
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-51.38
Wall Street Target
$54.17
(+53.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: March 30, 2026 6:18 PM ET
Data refreshes hourly during market hours. Next update: 7:18 PM
Data refreshes hourly during market hours. Next update: 7:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COGT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Fairmount Funds Manageme…
SELL
3500000 shares
2026-01-22
Evan Kearns
SELL
65000 shares
2025-12-26
Jessica Sachs
SELL
82642 shares
2025-12-26
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 48 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 45 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
13 analysts |
$54 | 57 HOLD |
Advanced COGT Option Strategies
Professional options setups generated by AI based on today's COGT price and gamma walls.
